2025-03-17T15:31:50-05:00 2024-06-30 911194016 CLARK NUBER PS 10900 NE 4TH STREET SUITE 1400 BELLEVUE WA 98004 990 2023-07-01 916057438 NORTHWEST KIDNEY CENTERS NORT 2062922771 12901 20TH AVENUE S SEATAC WA 98168 JENNIFER ESLAVA VICE PRESIDENT OF FINANCE/CFO 2062922771 2025-03-11 1 1 SARA ELIZABETH H JONES P00235495 4254544919 2025-03-11 2023 2025-03-06 01:10:19Z REBECCA FOX 12901 20TH AVENUE S SEATAC WA 98168 201239249 0 X WWW.NWKIDNEY.ORG X 1962 WA TO PROMOTE THE OPTIMAL HEALTH, QUALITY OF LIFE AND INDEPENDENCE OF PEOPLE WITH KIDNEY DISEASE THROUGH PATIENT CARE, EDUCATION, AND RESEARCH. 12 10 1024 520 0 0 1953543 1820437 129378506 137404413 3368502 3635444 -1717256 -1270203 132983295 141590091 615673 373956 0 0 73418319 79920846 0 0 1014657 61878616 59850937 135912608 140145739 -2929313 1444352 290233438 292404866 121973180 119381576 168260258 173023290 X NORTHWEST KIDNEY CENTERS' (NKC) MISSION IS TO PROMOTE THE OPTIMAL HEALTH, QUALITY OF LIFE AND INDEPENDENCE OF PEOPLE WITH KIDNEY DISEASE THROUGH PATIENT CARE, EDUCATION AND RESEARCH. NORTHWEST KIDNEY CENTERS IS A NOT-FOR-PROFIT, LOCALLY MANAGED PROVIDER OF KIDNEY DIALYSIS, PUBLIC HEALTH EDUCATION AND RESEARCH INTO THE CAUSES AND TREATMENTS OF CHRONIC KIDNEY DISEASE. FOUNDED IN SEATTLE IN 1962, IT WAS THE WORLD'S FIRST DIALYSIS ORGANIZATION. AMONG THE EIGHTH LARGEST DIALYSIS PROVIDERS IN THE COUNTRY, IT IS AN INFLUENTIAL MODEL BECAUSE OF ITS HIGH-QUALITY SERVICES, DEEP COMMUNITY CONNECTIONS AND GENEROUS DONOR SUPPORT. 0 0 114260591 135948751 IN THE YEAR ENDED JUNE 30, 2024, NORTHWEST KIDNEY CENTERS PROVIDED 292,559 DIALYSIS TREATMENTS, ESSENTIAL TO SUSTAIN THE LIVES OF PEOPLE WITH KIDNEY FAILURE. NKC SERVED A TOTAL OF 2,729 PATIENTS. THE ORGANIZATION PROVIDED PATIENT CARE IN TWENTY (20) FREE-STANDING CLINICS AND IN EIGHT (8) LOCAL HOSPITALS AND SUPERVISED SELF-DIALYSIS TREATMENTS IN THE HOMES OF PATIENTS THROUGHOUT THE COMMUNITY. NKC SPENT OVER $20 MILLION MORE ON THE CARE OF PATIENTS WITH MEDICARE AND MEDICAID INSURANCE THAN THE PROGRAMS REIMBURSED US FOR. IN ADDITION, NKC PROVIDED MORE THAN $3.5 MILLION IN CHARITY CARE. NORTHWEST KIDNEY CENTERS' RENAL SPECIALTY PHARMACY, A RARITY IN THE NATION, SERVED MORE THAN 1,913 DIALYSIS PATIENTS AND KIDNEY TRANSPLANT RECIPIENTS DURING THE YEAR. 1029722 NORTHWEST KIDNEY CENTERS OFFERS FREE CLASSES THAT HELP PEOPLE WITH CHRONIC KIDNEY DISEASE (CKD) PRESERVE KIDNEY FUNCTION, CHOOSE APPROPRIATE TREATMENT, TAKE CARE OF A TRANSPLANTED KIDNEY AND IN GENERAL BE AN EMPOWERED PARTNER IN THEIR KIDNEY HEALTH CARE. THE CLASS PROGRAM PROVIDES OUTREACH TO PEOPLE WHO ARE NOT DIALYSIS PATIENTS AND MAY HELP THEM KEEP THEIR KIDNEYS HEALTHY ENOUGH SO THAT THEY NEVER NEED TO GO ON DIALYSIS OR CAN DELAY ITS ONSET. THE PATIENT-FOCUSED, EVIDENCE-BASED CURRICULUM WAS DEVELOPED BY NORTHWEST KIDNEY CENTERS. THERE WERE 545 CHRONIC KIDNEY DISEASE EDUCATION PARTICIPANTS. IN ADDITION TO ITS FREE CLASSES, NORTHWEST KIDNEY CENTERS CONNECTED WITH 89 COMMUNITY-BASED ORGANIZATIONS, PARTICIPATED IN 32 COMMUNITY EVENTS RESULTING IN 3,145 TOUCHPOINTS WITH PEOPLE THROUGH OUR OUTREACH EFFORTS. 335433 335433 NORTHWEST KIDNEY CENTERS PROVIDED NEPHROLOGY FELLOWSHIPS FOR THREE (3) PHYSICIANS TO DO ADVANCED STUDY OF KIDNEY DISEASE AND RENAL CARE AT THE UNIVERSITY OF WASHINGTON. WE AIM TO ENSURE THAT PROFESSIONAL CARE WILL CONTINUE TO BE AVAILABLE FOR FUTURE KIDNEY PATIENTS. WE PROVIDED SIGNIFICANT SUPPORT FOR THE KIDNEY RESEARCH INSTITUTE (KRI), A COLLABORATION BETWEEN NORTHWEST KIDNEY CENTERS AND UW MEDICINE. THE KIDNEY RESEARCH INSTITUTE HAS HAD HUNDREDS OF STUDIES UNDERWAY, FOCUSING ON THE ROLE OF GENETICS, IMPACT OF LIFESTYLE, AND DIABETES IN KIDNEY DISEASE, AS WELL AS WAYS TO IMPROVE DIALYSIS OUTCOMES. THE KIDNEY RESEARCH INSTITUTE PUBLISHED THOUSANDS OF SCIENTIFIC PAPERS IN PEER-REVIEWED JOURNALS FROM ITS INCEPTION IN 2008. NORTHWEST KIDNEY CENTERS' INVESTMENT IN THE KIDNEY RESEARCH INSTITUTE HAD HELPED TO LEVERAGE HUNDREDS OF MILLIONS IN FUNDING FROM THE NATIONAL INSTITUTES OF HEALTH. 38523 38523 OTHER PROGRAM SERVICES INCLUDE 1) EMERGENCY ASSISTANCE TO NEEDY PATIENTS FOR FOOD, HOUSING AND OTHER EXPENSES. IN FY24, WE PROVIDED A TOTAL OF $23,612 TO 40 PATIENTS. 2) EMPLOYEE SCHOLARSHIPS TO 11 EMPLOYEES TOTALING $14,911 IN FY24. 38523 38523 115664269 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 0 1 0 0 0 0 0 0 0 1 1 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 65 0 1 1024 1 0 0 0 0 0 1 1 0 0 0 0 0 0 X 12 10 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 0 WA X JENNIFER ESLAVA 2062922771 12901 20TH AVENUE S SEATAC WA 98168 REBECCA FOX CEO & PRESIDENT 50.00 X X 660629 0 39739 RICHARD GREAVES BOARD CHAIR 1.00 X X 0 0 0 DOUGLAS ROSS BOARD VICE CHAIR 1.00 X X 0 0 0 MICHAEL SUTTERS BOARD MEMBER, CONTRACTED MEDICAL DIR. 1.00 X 99000 0 0 SHIKA PAPPOE BOARD MEMBER 1.00 X 0 0 0 JENNIFER BRENNER BOARD MEMBER 1.00 X 0 0 0 HINA PATEL BOARD MEMBER 1.00 X 0 0 0 REX OCHI BOARD MEMBER 1.00 X 0 0 0 MARK OSTROW BOARD MEMBER 1.00 X 0 0 0 QUITA HIGHSMITH BOARD MEMBER 1.00 X 0 0 0 SANJIT REDDY BOARD MEMBER 1.00 X 0 0 0 LAUREN GARDNER BOARD MEMBER 1.00 X 0 0 0 SUZANNE WATNICK CHIEF MEDICAL OFFICER THRU 12/23 50.00 X 424616 0 11111 ELIZABETH MCNAMARA CHIEF ADMIN OFFICER THRU 09/23 50.00 X 287066 0 8974 ROBIN LARMER VP LEGAL AFFAIRS & CCO 50.00 X 283450 0 14740 LIBERTY STANSBERRY VP OF HR THRU 10/23 50.00 X 230129 0 7723 MATTHEW RIVARA CHIEF MEDICAL OFFICER 50.00 X 124761 0 0 JENNIFER ESLAVA VP OF FINANCE/CFO 50.00 X 108401 0 15533 KAREN SCHARTMAN ACTING VP OF FINANCE/CFO THRU 08/23 40.00 X 316500 0 0 WILLIAM AZZAM REGISTERED NEPHROLOGY NURSE 50.00 X 258276 0 16273 TODD BUI REGISTERED NEPHROLOGY NURSE 50.00 X 248077 0 16465 TANYA WOLFF REGISTERED NEPHROLOGY NURSE 50.00 X 225157 0 15728 MICHAEL KELLOGG SR DIRECTOR FACILITY PLANNING 50.00 X 215272 0 32286 SARAH CORDEIRO VP OF BUSINESS DEVELOPMENT 50.00 X 214137 0 36639 3695471 0 215211 181 0 1 0 ASCEND CLINICAL LLC PO BOX 45021 SAN FRANCISCO CA 941450021 LABORATORY SERVICES 1697686 HEALTHCARE SUPPORT STAFFING LLC 101 SOUTH HALL LANE MAITLAND FL 32751 STAFFING SERVICES 751006 POLYCLINIC PO BOX 22608 SEATTLE WA 98122 CLINICAL SERVICES 355180 CLARK NUBER PS 10900 NE 4TH ST SUITE 1400 BELLEVUE WA 980045841 AUDIT AND TAX 146772 VIRGINIA MASON MEDICAL CENTER 1100 9TH AVE M10AC SEATTLE WA 98101 STAFFING SERVICES 140167 6 647329 1173108 141192 1820437 DIALYSIS 621400 131258470 131258470 PATIENT LAB REVENUE 621500 5389122 5389122 OTHER MEDICAL RELATED 621400 739247 739247 INSUR PREMIUM REIMBURS 621400 17574 17574 137404413 2971027 2971027 324046 0 324046 324046 324046 55009398 16532 54361513 0 647885 16532 664417 664417 78630 647329 295447 -216817 -216817 20800 0 20800 20800 3516802 4992198 -1475396 -1475396 REIMBURSEMENTS 900099 57188 57188 MED RECORDS/COUNSELING 900099 19734 19734 242 242 77164 141590091 135948751 0 3820903 335433 335433 38523 38523 2632372 216000 2416372 62906983 52248808 10014846 643329 2322396 1968830 332626 20940 6643046 5495522 1090249 57275 5416049 4406810 955515 53724 1752850 1674250 78600 166427 2381 164046 215183 215183 77500 77500 166299 166299 6173131 2318503 3691156 163472 140590 46196 68355 26039 1928707 1714058 186446 28203 4617419 3935457 650015 31947 10037382 9373615 660213 3554 328779 145258 155780 27741 147040 39288 107352 400 1573473 1489300 84173 6734625 6525689 203090 5846 426438 130892 295546 SUPPLIES 20475542 20260949 184015 30578 LAB TESTING 1426887 1378535 48352 REPAIRS & MAINTENANCE 667397 495917 170935 545 TAXES & LICENSES 511936 126955 384791 190 2283332 1297100 1065358 -79126 140145739 115664269 23466813 1014657 5165418 10885521 838107 713552 122729 224937 30578880 27418075 1661434 1263718 1393594 1529525 258455913 97364356 136040746 161091557 91679495 71596353 959562 0 21793473 17681628 290233438 292404866 17146269 20811814 0 50010 242963 201204 80390501 78822627 24193447 19495921 121973180 119381576 X 162910639 167637269 5349619 5386021 168260258 173023290 290233438 292404866 X 1444352 3219961 98719 X 0 1 X 1 0 X 6649783 4755799 5190539 1953543 1820437 20370101 125457680 126078883 127518165 132783036 140940949 652778713 132107463 130834682 132708704 134736579 142761386 673148814 82922 29387 47050 77908 87376 324643 0 82922 29387 47050 77908 87376 324643 672824171 1507117 1220626 1389334 2912553 3295073 10324703 1507117 1220626 1389334 2912553 3295073 10324703 18147 13412 58330 25489 57430 172808 133632727 132068720 134156368 137674621 146113889 683646325 0.98420 0.98610 0.01510 0.01320 X SCHEDULE A, PART III, LINE 12, EXPLANATION OF OTHER INCOME: MISC INCOME - 2019 AMOUNT: $ 1,364. 2020 AMOUNT: $ 308. 2021 AMOUNT: $ 124. 2022 AMOUNT: $ 204. 2023 AMOUNT: $ 242. REIMBURSEMENTS - 2019 AMOUNT: $ 16,783. 2020 AMOUNT: $ 10,992. 2021 AMOUNT: $ 58,206. 2022 AMOUNT: $ 25,285. 2023 AMOUNT: $ 57,188. CONSIGNMENT SALES - 2020 AMOUNT: $ 2,112. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 1 50000 1 25000 0 0 75000 0 PART II-B, LINE 1: NORTHWEST KIDNEY CENTERS ENGAGED IN LOBBYING AT THE STATE AND FEDERAL LEVEL DURING THE FISCAL YEAR ENDED 6/30/24. GRANTS TO ORGANIZATIONS FOR LOBBYING PURPOSES INCLUDE PAYMENTS TO KIDNEY RELATED LOBBYING ORGANIZATIONS. NORTHWEST KIDNEY CENTERS ACTIVELY WORKS WITH INDUSTRY ORGANIZATIONS SUCH AS NKCA (NON-PROFIT KIDNEY CARE ALLIANCE) AND KCC (KIDNEY CARE COUNCIL) TO WORK WITH POLICY MAKERS AND INDUSTRY REPRESENTATIVES TO GUIDE POLICY AT THE NATIONAL AND STATE LEVELS. 7215578 11558 587165 294160 7520141 7076690 18377 408191 287680 7215578 8359321 17146 -1021170 278607 7076690 7089980 17221 1520344 268224 8359321 6760332 266203 251217 187772 7089980 0.53319 0.35856 0.10825 0 0 20271275 20271275 87549142 17959974 69589168 52352967 38140843 14212124 53858585 41263539 12595046 44423944 44423944 161091557 SECURITY DEPOSITS 119370 DEFERRED COMPENSATION 178444 BENEFICIAL INTEREST IN SPLIT INTEREST AGREEMENTS 1386164 RIGHT OF USE ASSETS 15997650 17681628 DEFERRED COMPENSATION 178444 DEFERRED RENT 864930 LEASE LIABILITY 18452547 19495921 149582598 3219961 -348800 2871161 146711437 166299 -5287645 -5121346 141590091 144819566 5287645 5287645 139531921 166299 447519 613818 140145739 PART V, LINE 4: ENDOWMENT FUNDS ARE USED FOR A WIDE VARIETY OF PATIENT SUPPORT NEEDS AND KIDNEY RESEARCH, INCLUDING CHRONIC KIDNEY DISEASE PATIENT EDUCATION, TRANSPORTATION SUPPORT TO TREATMENT APPOINTMENTS, TRAINING FOR PATIENTS TO PERFORM DIALYSIS TREATMENTS FROM THEIR HOME, AND ACCESS TO CLINICAL TRIALS THROUGH OUR PARTNERSHIP WITH THE KIDNEY RESEARCH INSTITUTE. PART XI, LINE 2D - OTHER ADJUSTMENTS: CHANGE IN VALUE OF SPLIT INTEREST AGREEMENT 99,388. BAD DEBT EXPENSE REPORTED ON PART IX -447,519. PRIOR YEAR PLEDGE WRITEOFFS -669. PART XI, LINE 4B - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSES REPORTED ON PART VIII -295,447. PHARMACY COST OF GOODS SOLD REPORTED ON PART VIII -4,992,198. PART XII, LINE 2D - OTHER ADJUSTMENTS: SPECIAL EVENT EXPENSES REPORTED ON PART VIII 295,447. PHARMACY COST OF GOODS SOLD REPORTED ON PART VIII 4,992,198. PART XII, LINE 4B - OTHER ADJUSTMENTS: BAD DEBT EXPENSE REPORTED ON PART IX 447,519. GALA 725959 647329 78630 25702 39872 0 229873 725959 647329 78630 25702 39872 229873 295447 -216817 20800 1 1.00000 20800 20800 WA 1 0 0 0 1.00000 0.00000 JACQUI WEBER 12901 20TH AVENUE S SEATAC WA 98168 0 JACQUI WEBER 0 MAINTAINED ALL RECORDS OF RAFFLE HELD FOR THE ANNUAL GALA X 0 1 UNIVERSITY OF WASHINGTON 3917 UNIVERSITY WAY NE SEATTLE WA 98105 916001537 GOVERNMENT 335433 0 SEE SCHEDULE I, PART IV. 1 0 INDIVIDUAL GRANTS 40 23612 SCHOLARSHIPS 11 14911 PART I, LINE 2: GIFT TO THE UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE (UWSOM)/DIVISION OF NEPHROLOGY: AS DESCRIBED IN THE "GIFT AGREEMENT BETWEEN NORTHWEST KIDNEY CENTERS AND UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE/DIVISION OF NEPHROLOGY" (DATED AUGUST 21, 2006) ALONG WITH ITS FOLLOWING 15 ANNUAL EXTENSIONS; THE FOLLOWING PROVISIONS WERE ESTABLISHED IN REGARD TO PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS: NKC WILL PROVIDE GIFTS DIRECTED TO THE UW DIVISION OF NEPHROLOGY TO A) ENHANCE THE TRAINING OF FELLOWS IN NEPHROLOGY, AND B) TO SUPPORT BASIC RESEARCH INTO THE CAUSES AND CURES OF KIDNEY DISEASE, AND TO SUPPORT THE ACTIVITIES OF THE KIDNEY RESEARCH INSTITUTE AT THE UNIVERSITY OF WASHINGTON. NKC AND UWSOM AGREE THAT THESE GIFTS WILL NOT BE USED TO PAY UWSOM OVERHEAD, DEPARTMENT ASSESSMENTS, OR INDIRECT COSTS ON STUDIES. THE PARTIES FURTHER AGREE THAT THE UWSOM IS RESPONSIBLE FOR STEWARDSHIP OF THESE FUNDS AND WILL DIRECTLY UTILIZE THE FULL AMOUNT OF THE GIFTS. THERE ARE NO CONTRACTUAL ARRANGEMENTS ASSOCIATED WITH THE FUNDS, WHICH REQUIRE OR PROVIDE FOR COMPLIANCES WITH PROTOCOLS, PATIENT RIGHTS, TECHNOLOGY TRANSFER OR OTHER SIMILAR CONDITIONS OR PROPRIETARY INFORMATION WITH NKC. PARAGRAPH D-PERIODICALLY UWSOM WILL PROVIDE NKC WRITTEN AND VERBAL REPORTS AND INFORMATIONAL PRESENTATIONS REGARDING THE ACTIVITIES OF THE FUNDED FELLOWS, THE BASIC RESEARCH CONDUCTED WITH NKC FUNDING, AND ACTIVITIES OF THE KIDNEY RESEARCH INSTITUTE, AT A SCHEDULE MUTUALLY AGREED UPON BETWEEN THE NKC PRESIDENT AND CEO AND THE UW HEAD, DIVISION OF NEPHROLOGY. UPON REQUEST UWSOM SHALL PROVIDE NKC INFORMATION REGARDING THE AMOUNT AND TYPE OF EXPENDITURES ASSOCIATED WITH GIFTS TO THE UWSOM. AT THE END OF THE PERIOD COVERED BY THIS GIFT AGREEMENT ANY UNSPENT NKC GIFT FUNDS TO UWSOM SHOULD REMAIN DESIGNATED FOR USE BY THE NEPHROLOGY FELLOWSHIP PROGRAM, BASIC RESEARCH ENDEAVORS, OR KIDNEY RESEARCH INSTITUTE FOR USE IN SUBSEQUENT FISCAL YEARS. ALL FUNDS REMAIN WITH UWSOM AS A GIFT FOR THE KRI. INDIVIDUAL GRANTS: THE EMERGENCY FUND PROGRAM PROVIDES SUPPORT FOR SELECT NKC PATIENTS CURRENTLY RECEIVING DIALYSIS, OR PATIENTS OF NKC WHO HAVE RECEIVED A KIDNEY TRANSPLANT WITHIN THE PREVIOUS THREE YEARS AND RESIDE WITHIN WASHINGTON STATE. GRANTS OF UP TO $250 PER PATIENT MAY BE AWARDED IN A GIVEN TWELVE MONTH PERIOD. PAYMENT IS IN THE FORM OF A CHECK OR GROCERY STORE GIFT CARD. REQUESTS FOR LARGER AMOUNTS WILL BE CONSIDERED INDIVIDUALLY ON AN EXCEPTION BASIS. NKC SOCIAL WORKERS ARE RESPONSIBLE FOR OBTAINING DOCUMENTATION OF THE PATIENT'S NEED AND INVESTIGATION OF ALL OTHER POSSIBLE COMMUNITY RESOURCES AVAILABLE TO MEET THE NEED. EACH GRANT MUST BE APPROVED BY THE PATIENT'S SOCIAL WORKER, AND THE SOCIAL SERVICES DIRECTOR. THE GRANT WILL BE PAID TO A THIRD PARTY FOR THE SERVICE OR MATERIAL NEEDED BY THE PATIENT. CHECKS WILL NOT BE MADE OUT TO THE PATIENT DIRECTLY. SCHOLARSHIPS: EMPLOYEE SCHOLARSHIP APPLICATIONS ARE REVIEWED BY DEVELOPMENT STAFF TO ENSURE APPLICATIONS ARE COMPLETE, AND BY HUMAN RESOURCES (HR) TO ENSURE APPLICANTS MEET MINIMUM QUALIFICATIONS (EMPLOYED AT LEAST ONE YEAR, FULL-TIME OR REGULAR PART-TIME (AT LEAST 24 HOURS PER WEEK)). THOSE WHO MEET MINIMUM QUALIFICATIONS ARE SENT TO THE EMPLOYEE SCHOLARSHIP COMMITTEE TO BE RATED USING A SCORING MATRIX OF SPECIFIC CRITERIA. THE COMMITTEE IS COMPRISED OF AN HR REPRESENTATIVE, CKD PROGRAM MANAGER (MSW) AND VP DEVELOPMENT. THE HIGHEST RATED APPLICANTS THEN INTERVIEW WITH THE COMMITTEE. AFTER THAT, THE COMMITTEE DECIDES WHO WILL RECEIVE A SCHOLARSHIP AND HOW MUCH. THE ACTUAL AMOUNTS AWARDED DEPEND ON RESTRICTIONS PLACED BY THE DONORS ABOUT HOW THE SCHOLARSHIP FUNDS CAN BE USED AND THE AMOUNT AVAILABLE IN ANY GIVEN YEAR. SCHEDULE I, PART II, LINE 1, COLUMN H: RESEARCH GRANTS ARE AWARDED TO UNIVERSITY PHYSICIANS WHO ARE CONDUCTING STUDIES, WHICH ARE DEDICATED TO RESEARCHING CAUSES AND CURES OF CONDITIONS RELATING TO KIDNEY DISEASES. FELLOWSHIPS ARE AWARDED TO THE UNIVERSITY OF WASHINGTON TO PROVIDE SALARY FUNDS FOR PHYSICIANS IN TRAINING TO BECOME NEPHROLOGISTS WHO CARE FOR PATIENTS WITH KIDNEY DISEASE. THE KIDNEY RESEARCH INSTITUTE IS A UNIVERSITY OF WASHINGTON BASED ORGANIZATION THAT IS DEDICATED TO THE RESEARCH OF KIDNEY DISEASE. X X X X X X 1 0 0 0 0 0 0 1 0 REBECCA FOX CEO & PRESIDENT 557455 0 100000 0 3174 0 14931 0 24808 0 700368 0 0 0 SUZANNE WATNICK CHIEF MEDICAL OFFICER THRU 12/23 422407 0 0 0 2209 0 7533 0 3578 0 435727 0 0 0 KAREN SCHARTMAN ACTING VP OF FINANCE/CFO THRU 08/23 316500 0 0 0 0 0 0 0 0 0 316500 0 0 0 ROBIN LARMER VP LEGAL AFFAIRS & CCO 244988 0 34580 0 3882 0 4577 0 10163 0 298190 0 0 0 ELIZABETH MCNAMARA CHIEF ADMIN OFFICER THRU 09/23 285935 0 0 0 1131 0 8974 0 0 0 296040 0 0 0 WILLIAM AZZAM REGISTERED NEPHROLOGY NURSE 258175 0 0 0 101 0 8417 0 7856 0 274549 0 0 0 TODD BUI REGISTERED NEPHROLOGY NURSE 247944 0 0 0 133 0 8609 0 7856 0 264542 0 0 0 SARAH CORDEIRO VP OF BUSINESS DEVELOPMENT 200779 0 12900 0 458 0 2028 0 34611 0 250776 0 0 0 MICHAEL KELLOGG SR DIRECTOR FACILITY PLANNING 213172 0 0 0 2100 0 4595 0 27691 0 247558 0 0 0 TANYA WOLFF REGISTERED NEPHROLOGY NURSE 224167 0 0 0 990 0 7872 0 7856 0 240885 0 0 0 LIBERTY STANSBERRY VP OF HR THRU 10/23 190996 0 0 0 39133 0 0 0 7723 0 237852 0 0 0 PART I, LINE 4A IN 2023, LIBERTY STANSBERRY RECEIVED $38,461 IN SEVERANCE PAY. PART I, LINE 7 THE CEO & PRESIDENT PARTICIPATES IN AN INCENTIVE PLAN DESIGNED FOR THIS OFFICE-HOLDER ALONE. THE PURPOSE OF THIS PLAN IS TO ALIGN THE PRESIDENT'S INTERESTS WITH THOSE OF THE BOARD AND NKC'S BROADER CONSTITUENTS AND TO RECOGNIZE SPECIAL CONTRIBUTIONS TO NKC'S FINANCIAL AND OPERATIONAL SUCCESS. THE COMPENSATION COMMITTEE OF THE BOARD HAS BOARD-DELEGATED RESPONSIBILITY FOR ESTABLISHING THE TOTAL COMPENSATION PACKAGE FOR THE CEO, AND FOR APPROVING THE CEO'S COMPENSATION PACKAGE. THE COMPENSATION COMMITTEE MEETS ANNUALLY TO ESTABLISH REASONABLE FINANCIAL AND OTHER GOALS FOR THE COMING YEAR. AT THE CONCLUSION OF THE YEAR, THE COMPENSATION COMMITTEE REVIEWS PERFORMANCE COMPARED TO THE PREDETERMINED GOALS, DETERMINES APPROPRIATE INCENTIVE COMPENSATION AS REASONABLY DETERMINED BY THE COMMITTEE AT ITS DISCRETION AND APPROVES GOALS FOR THE FOLLOWING YEAR. THE CHAIR OR HIS OR HER DESIGNATE WILL MEET WITH THE CEO TO REVIEW PRIOR YEAR PERFORMANCE AND THE CORRESPONDING INCENTIVE AWARD AND THE COMING YEAR'S FINANCIAL AND OPERATIONAL GOALS. A WASHINGTON HEALTH CARE FACILITIES AUTHORITY 2021 SERIES A 911108929 NONEAVAIL 2021-05-31 51300000 PREVIOUS PAY OFF, ISSUANCE COSTS 0 0 0 B WASHINGTON HEALTH CARE FACILITIES AUTHORITY 2021 SERIES B 911108929 NONEAVAIL 2021-05-31 28600000 PREVIOUS PAY OFF, CAPITAL IMPROVEMENTS 0 0 0 A 51300000 1190500 50109500 1 0 1 1 B 61023 28600000 27520000 1080000 0 0 1 1 A 0 0 0 0 0.00000 0.00000 0.00000 0 0 1 B 0 0 0 0 0.00000 0.00000 0.00000 0 0 1 A 0 1 0 0 0 0 0 0 1 B 0 1 0 0 0 0 0 0 1 A 1 B 1 X 3 37449 MARKET PRICE X AUCTION ITEMS 22 103743 ESTIMATED FAIR VALUE 0 0 1 0 PART I, COLUMN (B): THE NUMBER IN PART I, COLUMN (B) FOR SECURITIES REPRESENTS THE NUMBER OF CONTRIBUTIONS RECEIVED. FOR AUCTION ITEMS, THE NUMBER OF ITEMS CONTRIBUTED. FORM 990, PART I, LINE 6: NORTHWEST KIDNEY CENTERS IS LED BY A VOLUNTEER BOARD OF TRUSTEES AND BY A FOUNDATION BOARD THAT HELPS RAISE MONEY AND MAKE CONNECTIONS. THEY ARE JOINED BY AN ESTIMATED 500 OTHER VOLUNTEERS AS NEEDED TO STAFF EVENTS FOCUSED ON FUNDRAISING OR THE COMMUNITY. ACCORDING TO OUR RECORDS, DURING FY24, NORTHWEST KIDNEY CENTERS CONNECTED WITH 89 COMMUNITY-BASED ORGANIZATIONS, PARTICIPATED IN 32 COMMUNITY EVENTS RESULTING IN 3,145 TOUCHPOINTS WITH PEOPLE THROUGH OUR OUTREACH EFFORTS. FORM 990, PART VI, SECTION B, LINE 11B THE BOARD OF TRUSTEES' FINANCE, AUDIT AND INVESTMENT COMMITTEE REVIEWED THE 2023 FORM 990 BEFORE IT WAS FILED. THE 2023 FORM 990 WAS ALSO PROVIDED TO THE FULL BOARD OF TRUSTEES BEFORE FILING. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION REQUIRES ALL BOARD MEMBERS, OFFICERS AND MANAGERS ANNUALLY TO DISCLOSE FINANCIAL INTERESTS AND PERSONAL RELATIONSHIPS WITH POTENTIAL TO GIVE RISE TO A CONFLICT. EACH OF THEM GETS A COPY OF THE CONFLICT-OF-INTEREST POLICY ALONG WITH A LIST OF VENDORS AND CONTRACTORS RECIPIENTS ARE REQUIRED TO INDICATE ANY INTEREST IN THE COMPANIES LISTED. ALL DISCLOSURES ARE REVIEWED BY THE BOARD CHAIR, THE CHAIR OF THE BOARD'S COMPLIANCE COMMITTEE, AND THE PRESIDENT/CEO. THEY DECIDE IF ANY POTENTIAL CONFLICT EXISTS AND THEN FOLLOW UP WITH SPECIFIC INDIVIDUALS AS NEEDED, AND REPORT TO THE BOARD OF TRUSTEES ON THE COMPLETED REVIEW PROCESS. INDIVIDUAL BOARD MEMBERS ARE REMINDED TO ABSTAIN FROM VOTES IF THERE IS A POTENTIAL CONFLICT OF INTEREST. THE CONFLICT-OF-INTEREST POLICY IS SHARED WITH ALL NEW EMPLOYEES AND NEW BOARD MEMBERS AND IT IS POSTED ON NORTHWEST KIDNEY CENTERS' INTRANET. FORM 990, PART VI, SECTION B, LINE 15 NORTHWEST KIDNEY CENTERS BOARD OF TRUSTEES' COMPENSATION COMMITTEE REVIEWS THE PRESIDENT/CEO'S COMPENSATION. THE COMMITTEE CONSISTS OF THREE INDEPENDENT BOARD MEMBERS WHO DO NOT RECEIVE ANY COMPENSATION FROM NORTHWEST KIDNEY CENTERS. THIS COMMITTEE CONTRACTS WITH AN INDEPENDENT FIRM TO EVALUATE THE ORGANIZATION'S COMPLIANCE WITH FIDUCIARY AND IRS RESPONSIBILITIES. THIS OUTSIDE REVIEW USES HOSPITAL AND OTHER HEALTH CARE COMPENSATION DATA TO FORMULATE A RECOMMENDATION ON TOTAL COMPENSATION RELATIVE TO SIZE, COMPLEXITY, MARKET LOCATION, AND NATURE OF THE ORGANIZATION. THE COMPENSATION COMMITTEE IS DELEGATED BY THE EXECUTIVE COMMITTEE OF THE BOARD TO APPROVE A SALARY FOR THE PRESIDENT/CEO. THE PROCESS WAS PERFORMED IN 2023 FOR THE COMPENSATION PACKAGE OF THE PRESIDENT/CEO. DATA REGARDING THE VICE PRESIDENTS' PAY HISTORY, CURRENT PAY AND PROPOSED ADJUSTMENTS WERE PROVIDED TO THE NORTHWEST KIDNEY CENTERS COMPENSATION COMMITTEE, WHO DETERMINE THAT SUCH AMOUNTS ARE CONSISTENT WITH MARKET PARAMETERS. COMPENSATION FOR THE VICE PRESIDENTS WAS LAST REVIEWED IN 2023. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S BYLAWS, ARTICLES OF INCORPORATION, AND CONFLICT OF INTEREST POLICY ARE AVAILABLE ON REQUEST, CONTACT INFO@NWKIDNEY.ORG. THE FISCAL YEAR FINANCIAL RESULTS ARE PUBLISHED IN THE ANNUAL REPORT, AVAILABLE ON WWW.NWKIDNEY.ORG. FORM 990, PART XI, LINE 9: CHANGE IN VALUE OF SPLIT INTEREST AGREEMENT 99,388. PRIOR YEAR PLEDGES WRITTEN OFF -669.